To further verify this result, we collected 48 surgical specimens from glioma patients at the General Hospital of Ningxia Medical University from January 2014 to December 2016, performed SREBP1c and PER2 immunohistochemical staining, and scored the results of immunohistochemical staining according to the two grades. This evidence concerns the gene SREBF1 and central nervous system cancer.